Giuseppe Battaglia


Affiliation: IRCCS Neuromed
Country: Italy


  1. Moyanova S, De Fusco A, Santolini I, Celli R, Bucci D, Mastroiacovo F, et al. Abnormal Hippocampal Melatoninergic System: A Potential Link between Absence Epilepsy and Depression-Like Behavior in WAG/Rij Rats?. Int J Mol Sci. 2018;19: pubmed publisher
  2. Truini A, Piroso S, Pasquale E, Notartomaso S, Di Stefano G, Lattanzi R, et al. N-acetyl-cysteine, a drug that enhances the endogenous activation of group-II metabotropic glutamate receptors, inhibits nociceptive transmission in humans. Mol Pain. 2015;11:14 pubmed publisher
    ..These data lay the groundwork for investigating the therapeutic potential of NAC in patients with chronic pain. ..
  3. Romanelli P, Fardone E, Bucci D, Battaglia G, Bräuer Krisch E, Requardt H, et al. Microradiosurgical cortical transections generated by synchrotron radiation. Phys Med. 2015;31:642-6 pubmed publisher
  4. Busceti C, Di Pietro P, Riozzi B, Traficante A, Biagioni F, Nisticò R, et al. 5-HT(2C) serotonin receptor blockade prevents tau protein hyperphosphorylation and corrects the defect in hippocampal synaptic plasticity caused by a combination of environmental stressors in mice. Pharmacol Res. 2015;99:258-68 pubmed publisher
    ..Drugs that block 5-HT2C receptors might protect the hippocampus against the detrimental effect of environmental stressors. ..
  5. Battaglia G, Bruno V. Metabotropic glutamate receptor involvement in the pathophysiology of amyotrophic lateral sclerosis: new potential drug targets for therapeutic applications. Curr Opin Pharmacol. 2018;38:65-71 pubmed publisher
  6. Battaglia G, Riozzi B, Bucci D, Di Menna L, Molinaro G, Pallottino S, et al. Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 2015;74:126-36 pubmed publisher
    ..LY379268 had no significant effect on the mortality rate of SODG93A. These findings encourage the development of selective mGlu3 receptor agonists/enhancers as neuroprotective agents in ALS. ..
  7. Cannella M, Motolese M, Bucci D, Molinaro G, Gradini R, Bruno V, et al. Changes in the expression of genes encoding for mGlu4 and mGlu5 receptors and other regulators of the indirect pathway in acute mouse models of drug-induced parkinsonism. Neuropharmacology. 2015;95:50-8 pubmed publisher